Epiterna

Biotech · CH

Longevity biotech screening drugs to extend healthy lifespan in pets and people.

Funding history

Date	Round	Amount
Aug 2023	Funding round Swiss longevity startup Epiterna exited stealth with EUR10M from Daniel Ek's Prima Materia.	$10.8M

Prima Materia